Mertens LS, Mellema JJ, Sridhar S, van der Heijden MS, et al. Re: Neoadjuvant Sacituzumab Govitecan plus Pembrolizumab, Followed by Adjuvant Pembrolizumab, in Patients with Muscle-invasive Bladder Cancer (SURE-02): A Single-arm, Phase 2 Study. Eur Urol 2026 Jun 17:S0302-2838(26)02186-X. doi: 10.1016/j.eururo.2026.
PMID: 42303524